These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 17551779
1. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D, Capussotti L. World J Surg; 2007 Aug; 31(8):1643-51. PubMed ID: 17551779 [Abstract] [Full Text] [Related]
2. Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. Cieslak KP, Bennink RJ, de Graaf W, van Lienden KP, Besselink MG, Busch OR, Gouma DJ, van Gulik TM. HPB (Oxford); 2016 Sep; 18(9):773-80. PubMed ID: 27593595 [Abstract] [Full Text] [Related]
3. Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Guiu B, Quenet F, Escal L, Bibeau F, Piron L, Rouanet P, Fabre JM, Jacquet E, Denys A, Kotzki PO, Verzilli D, Deshayes E. Eur Radiol; 2017 Aug; 27(8):3343-3352. PubMed ID: 28101681 [Abstract] [Full Text] [Related]
4. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Surgery; 2008 Apr; 143(4):476-82. PubMed ID: 18374044 [Abstract] [Full Text] [Related]
5. Preoperative Portal Vein Embolization before Major Hepatectomy in Patients with Excess Bilirubin does not Affect Hypertrophy of Remnant Liver and Postoperative Outcomes. Sakakibara M, Kato A, Shimizu H, Ohtsuka M, Yoshitomi H, Furukawa K, Miyazaki M. Hepatogastroenterology; 2014 Jun; 61(132):908-15. PubMed ID: 26158140 [Abstract] [Full Text] [Related]
8. [Portal vein embolization: Present and future]. Piron L, Deshayes E, Escal L, Souche R, Herrero A, Pierredon-Foulongne MA, Assenat E, le Lam N, Quenet F, Guiu B. Bull Cancer; 2017 May; 104(5):407-416. PubMed ID: 28477870 [Abstract] [Full Text] [Related]
9. Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging. Sato Y, Matsushima S, Inaba Y, Sano T, Yamaura H, Kato M, Shimizu Y, Senda Y, Ishiguchi T. Korean J Radiol; 2015 May; 16(3):523-30. PubMed ID: 25995681 [Abstract] [Full Text] [Related]
10. Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization. Sakamoto Y, Shimada K, Nara S, Esaki M, Kajiwara T, Arai Y, Sano T, Yamamoto J, Kosuge T. Hepatogastroenterology; 2010 May; 57(97):22-8. PubMed ID: 20422866 [Abstract] [Full Text] [Related]
11. Using Dynamic 99mT c-GSA SPECT/CT fusion images for hepatectomy planning and postoperative liver failure prediction. Mao Y, Du S, Ba J, Li F, Yang H, Lu X, Sang X, Li S, Che L, Tong J, Xu Y, Xu H, Zhao H, Chi T, Liu F, Du Y, Zhang X, Wang X, Dong J, Zhong S, Huang J, Yu Y, Wang J. Ann Surg Oncol; 2015 Apr; 22(4):1301-7. PubMed ID: 25294018 [Abstract] [Full Text] [Related]
12. The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients. Lin XJ, Yang J, Chen XB, Zhang M, Xu MQ. J Surg Res; 2014 May 15; 188(2):489-95. PubMed ID: 24569034 [Abstract] [Full Text] [Related]
13. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L. Ann Surg Oncol; 2010 Aug 15; 17(8):2081-9. PubMed ID: 20237856 [Abstract] [Full Text] [Related]
14. Pre-hepatectomy portal vein embolization: single center experience. Cotroneo AR, Innocenti P, Marano G, Legnini M, Iezzi R. Eur J Surg Oncol; 2009 Jan 15; 35(1):71-8. PubMed ID: 18722746 [Abstract] [Full Text] [Related]